May 15, 2025 5:37 pm EDT VolitionRx Limited Announces First Quarter 2025 Financial Results and Business Update
May 12, 2025 8:30 am EDT VolitionRx Limited Schedules First Quarter 2025 Earnings Conference Call and Business Update
May 7, 2025 8:30 am EDT VolitionRX Limited: Outlines broad strategy to become the 'NETs company' worldwide through licensing and updates progress of Nu.Q® NETs test adoption
Apr 29, 2025 8:30 am EDT VolitionRX Limited: Revolutionizing the diagnosis and monitoring of life-altering diseases for both humans and animals in multi-billion dollar markets
Mar 31, 2025 4:05 pm EDT VolitionRx Limited Announces Full Fiscal Year 2024 Financial Results and Business Update
Mar 28, 2025 8:00 am EDT Volition Announces Two Poster Presentations at ESMO's European Lung Cancer Congress 2025
Mar 27, 2025 8:30 am EDT Volition to Host Virtual Investor Event on Nu.Q® Cancer, "A Look to the Future of Cancer Diagnostics", on April 9, 2025
Mar 26, 2025 8:00 am EDT VolitionRx Announces Pricing of up to $2.3 Million Registered Direct Offering
Mar 25, 2025 9:30 am EDT VolitionRx Limited Schedules Full Fiscal Year 2024 Earnings Conference Call and Business Update
